SCHEMBL24434816

SCHEMBL24434816

CC(C)OC(C)(C)c1csc(NC(=O)c2cccn2Cc2ccnc3ccccc23)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.43
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 3/20 0.43
ALOX15 P16050 2/20 0.43
LMNA P02545 3/20 0.40
TSHR P16473 3/20 0.40
HTT P42858 2/20 0.40
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 2/20 0.39
MAPK1 P28482 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TP53 P04637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 1/20 0.38
SCN3A Q9NY46 3/20 0.37
KDR P35968 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31466296 1.00 HPGD (0.43) HPGDALDH1A1HSD17B10ALOX15LMNA
SCHEMBL24435339 0.85 LMNA (0.44) HPGDALDH1A1HSD17B10ALOX15LMNA
SCHEMBL24435294 0.84 SCN3A (0.47) HPGDALDH1A1HSD17B10LMNATSHR
SCHEMBL24434883 0.84 SMN1; SMN2 (0.40) HPGDALDH1A1HSD17B10ALOX15LMNA
SCHEMBL24434781 0.84 SMN1; SMN2 (0.40) HPGDALDH1A1HSD17B10ALOX15LMNA
SCHEMBL24435307 0.84 SMN1; SMN2 (0.40) HPGDALDH1A1HSD17B10ALOX15LMNA
SCHEMBL24435129 0.84 SMN1; SMN2 (0.39) HPGDALDH1A1HSD17B10ALOX15LMNA
SCHEMBL24434670 0.84 SMN1; SMN2 (0.39) HPGDALDH1A1HSD17B10ALOX15LMNA
SCHEMBL24435151 0.83 SMN1; SMN2 (0.39) HPGDALDH1A1HSD17B10ALOX15LMNA
SCHEMBL31466364 0.83 SMN1; SMN2 (0.39) HPGDALDH1A1HSD17B10ALOX15LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G HPGD 2543/4885ALDH1A1 4817/4885HSD17B10 2073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.